Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: Lipid alterations and glucose intolerance
- 作者Richard P Ames
- 卷第106卷
- 印刷ISSN0002-8703
- 电子ISSN1097-6744
- 文件大小948.27KB
- 发表时间1983
- DOI10.1016/0002-8703(83)90176-x
Prediction of 1-Year Survival After Thrombolysis for Acute Myocardial Infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries TrialCaliff, R. M.; Pieper, K. S.; Lee, K. L.; Van de Werf, F.; Simes, R. J.; Armstrong, P. W.; Topol, E. J. · Circulation · 2000
Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: Results of the HIT-4 trialKarl-Ludwig Neuhaus; G.Peter Molhoek; Uwe Zeymer; Ulrich Tebbe; Karl Wegscheider; Rolf Schröder; Anne Camez; G.Jan Laarman; Gilles M Grollier; Dirk J.A Lok; Holger Kuckuck; Peter Lazarus · 1999
Efficacy of Streptokinase, but Not Tissue-Type Plasminogen Activator, in Achieving 90-Minute Patency After Thrombolysis for Acute Myocardial Infarction Decreases With Time to TreatmentP.Gabriel Steg; Thierry Laperche; Jean-Louis Golmard; Jean-Michel Juliard; Hakim Benamer; Dominique Himbert; Pierre Aubry · 1998
Comparison of the predictive value of ST segment elevation resolution at 90 and 180min after start of streptokinase in acute myocardial infarction. A substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 StudySCHRODER, R · European Heart Journal · 1999